Pediatric Injuries from Consumer Products and Strategies for Prevention
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Daily consumer products pose significant risks, causing millions of injuries and fatalities annually. Pediatric clinicians can educate parents on home hazards and recommend subscribing to government recall alerts for child safety.
Area Of Science
- Consumer product safety
- Pediatric health
- Public health
Background
- Millions of injuries and fatalities occur annually due to everyday consumer products.
- Consumer product-related incidents incur substantial medical costs, estimated at $1 trillion.
- Children are particularly vulnerable to hazards associated with consumer products.
Purpose Of The Study
- To highlight the risks of common household consumer products.
- To emphasize the role of pediatric clinicians in educating parents about home safety.
- To promote awareness of government recall alerts for consumer products.
Main Methods
- Review of injury and fatality data associated with consumer products.
- Identification of common childhood hazard patterns in homes.
- Dissemination of information through pediatric clinicians to new parents.
Main Results
- Consumer products are linked to 34.4 million injuries and 48,000 deaths each year.
- Significant financial burden due to medical costs associated with consumer product injuries.
- Potential for reduced pediatric injuries through targeted parental education.
Conclusions
- Pediatric clinicians play a crucial role in preventing consumer product-related injuries in children.
- Educating parents on home hazards and recall alerts is vital for child safety.
- Subscribing to government recall alerts (e.g., from CPSC.gov) is an essential safety measure for all households.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...